Weight loss and vascular inflammatory markers in overweight women with and without polycystic ovary syndrome

Reproductive BioMedicine Online

Volumn 25, Issue 5, 2012, Pages 500-503

  Moran, Lisa J ^a   Noakes, Manny ^b   Wittert, Gary A ^a   Clifton, Peter M ^c   Norman, Robert J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b CSIRO   (Australia)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

cardiovascular disease; inflammation; polycystic ovary syndrome; weight loss

Indexed keywords

INSULIN; INTERCELLULAR ADHESION MOLECULE 1; N(G),N(G) DIMETHYLARGININE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; HUMAN; HYPERANDROGENISM; INFLAMMATION; INSULIN RESISTANCE; MACRONUTRIENT; OBESITY; OVARY POLYCYSTIC DISEASE; PHYSICAL ACTIVITY; PROTEIN EXPRESSION; SECONDARY ANALYSIS; SMOKING; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; ARGININE; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYCYSTIC OVARY SYNDROME; VASCULAR CELL ADHESION MOLECULE-1; WAIST CIRCUMFERENCE; WEIGHT LOSS;

EID: 84868475255     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2012.07.013     Document Type: Article

References (12)

1. P. Andersen, I. Seljeflot, M. Abdelnoor, H. Arnesen, P.O. Dale, A. Lovik, and K. Birkeland Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome Metabolism 44 1995 611 616
2. S. Blankenberg, H.J. Rupprecht, C. Bickel, D. Peetz, G. Hafner, L. Tiret, and J. Meyer Circulating cell adhesion molecules and death in patients with coronary artery disease Circulation 104 2001 1336 1342
3. E. Diamanti-Kandarakis, T. Paterakis, K. Alexandraki, C. Piperi, A. Aessopos, I. Katsikis, N. Katsilambros, G. Kreatsas, and D. Panidis Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin Hum. Reprod. 21 2006 1426 1431
4. L.J. Moran, M. Noakes, P.M. Clifton, G.A. Wittert, D.P. Belobrajdic, and R.J. Norman C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome J. Clin. Endocrinol. Metab. 92 2007 2944 2951
5. L.J. Moran, S.K. Hutchison, C. Meyer, S. Zoungas, and H.J. Teede A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome Clin. Sci. (Lond.) 116 2009 761 770
6. F. Orio Jr., S. Palomba, T. Cascella, L. Tauchmanova, L.G. Nardo, S. Di Biase, D. Labella, T. Russo, S. Savastano, A. Tolino, F. Zullo, A. Colao, and G. Lombardi Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? Reprod. Biomed. Online 9 2004 505 510
7. F. Orio Jr., S. Palomba, T. Cascella, S. Di Biase, F. Manguso, L. Tauchmanova, L.G. Nardo, D. Labella, S. Savastano, T. Russo, F. Zullo, A. Colao, and G. Lombardi The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome J. Clin. Endocrinol. Metab. 90 2005 2 5
8. F. Orio Jr., S. Palomba, and A. Colao Cardiovascular risk in women with polycystic ovary syndrome Fertil. Steril. 86 2006 S20 S21
9. J.K. Pai, T. Pischon, J. Ma, J.E. Manson, S.E. Hankinson, K. Joshipura, G.C. Curhan, N. Rifai, C.C. Cannuscio, M.J. Stampfer, and E.B. Rimm Inflammatory markers and the risk of coronary heart disease in men and women N. Engl. J. Med. 351 2004 2599 2610
10. P. Rissanen, E. Vahtera, T. Krusius, M. Uusitupa, and A. Rissanen Weight change and blood coagulability and fibrinolysis in healthy obese women Int. J. Obes. Relat. Metab. Disord. 25 2001 212 218
11. A.M. Thogersen, J.H. Jansson, K. Boman, T.K. Nilsson, L. Weinehall, F. Huhtasaari, and G. Hallmans High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor Circulation 98 1998 2241 2247
12. V.P. Valkonen, H. Paiva, J.T. Salonen, T.A. Lakka, T. Lehtimaki, J. Laakso, and R. Laaksonen Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine [see comment] Lancet 358 2001 2127 2128